NCT00295828View on ClinicalTrials.gov

A Pilot Study for the Treatment of Iris Neovascularization With Macugen

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Iris NeovascularizationDiabetic Retinopathy
Interventions
OTHER

Pegaptanib Sodium Injection/Panretinal Photocoagulation

Pegaptanib Sodium Injection is a single dose prefilled syringe and is formulated as a 3.47 mg/mL solution. Combined with an ocular laser procedure.

PROCEDURE

Panretinal Photocoagulation (PRP)

Ocular Laser Procedure

Trial Locations (1)

77030

Robert Cizik Eye Clinic, Houston

Sponsors

Collaborators (1)

Eyetech Pharmaceuticals
All Listed Sponsors
collaborator

Eyetech Pharmaceuticals

INDUSTRY

lead

Hermann Eye Center

OTHER